Cutler Group’s Boston Scientific BSX Stock Holding History

Cutler Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$3K	Sell	4,300 -27,000	-86%	-$1.74M	﹤0.01%	1689
2023 Q4	$38K	Buy	31,300 +22,800	+268%	+$1.22M	﹤0.01%	1601
2023 Q3	$40K	Buy	8,500 +3,300	+63%	+$173K	﹤0.01%	1618
2023 Q2	$24K	Buy	+5,200	New	+$272K	﹤0.01%	1738
2022 Q3	–	Sell	-2,000	Closed	-$5K	–	4931
2022 Q2	$5K	Sell	2,000 -7,300	-78%	-$297K	﹤0.01%	3676
2022 Q1	$9K	Buy	+9,300	New	+$403K	﹤0.01%	3675
2020 Q4	–	Sell	-6,500	Closed	-$3K	–	4822
2020 Q3	$3K	Buy	6,500 +2,500	+63%	+$96.3K	﹤0.01%	3784
2020 Q2	$5K	Hold	4,000	–	–	﹤0.01%	3272
2020 Q1	$11K	Buy	+4,000	New	+$156K	﹤0.01%	2646
2018 Q3	–	Sell	-12,000	Closed	-$5K	–	4113
2018 Q2	$5K	Buy	+12,000	New	+$362K	﹤0.01%	3082
2017 Q1	–	Sell	-55,000	Closed	-$6K	–	6394
2016 Q4	$6K	Hold	55,000	–	–	﹤0.01%	4712
2016 Q3	$15K	Hold	55,000	–	–	﹤0.01%	3704
2016 Q2	$41K	Sell	55,000 -25,000	-31%	-$541K	﹤0.01%	2557
2016 Q1	$183K	Buy	+80,000	New	+$1.41M	0.01%	1073

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cutler Group's BSX Position: Q1 2024 in Review

Cutler Group reduced its Boston Scientific (BSX) stake by 28% in Q1 2024, selling an estimated $80.2K and leaving 3,140 shares worth $215K. The position accounts for 0.07% of the portfolio, ranked #266.

Cutler Group first reported a position in BSX in Q1 2016 and has held it in 24 quarters since. The position peaked at $1.44M in Q1 2016. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

Cutler Group held 3,140 shares of Boston Scientific worth $215K as of Q1 2024.
Cutler Group sold 1,247 Boston Scientific shares in Q1 2024, an estimated $80.2K.
Boston Scientific made up 0.07% of Cutler Group's portfolio in Q1 2024, its #266 holding.
Cutler Group first reported a position in Boston Scientific in Q1 2016 and has held it in 24 quarters since.
Cutler Group's Boston Scientific position peaked at $1.44M in Q1 2016.
1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.